SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-003956
Filing Date
2024-01-08
Accepted
2024-01-08 08:21:13
Documents
53
Period of Report
2024-01-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d110563d8k.htm   iXBRL 8-K 32688
2 EX-99.1 d110563dex991.htm EX-99.1 16781
3 EX-99.2 d110563dex992.htm EX-99.2 56326
8 GRAPHIC g110563ex99_2p10g1.jpg GRAPHIC 330760
9 GRAPHIC g110563ex99_2p11g1.jpg GRAPHIC 244599
10 GRAPHIC g110563ex99_2p12g1.jpg GRAPHIC 343869
11 GRAPHIC g110563ex99_2p13g1.jpg GRAPHIC 292936
12 GRAPHIC g110563ex99_2p14g1.jpg GRAPHIC 257774
13 GRAPHIC g110563ex99_2p15g1.jpg GRAPHIC 304639
14 GRAPHIC g110563ex99_2p16g1.jpg GRAPHIC 221889
15 GRAPHIC g110563ex99_2p17g1.jpg GRAPHIC 282609
16 GRAPHIC g110563ex99_2p18g1.jpg GRAPHIC 224440
17 GRAPHIC g110563ex99_2p19g1.jpg GRAPHIC 388446
18 GRAPHIC g110563ex99_2p1g1.jpg GRAPHIC 384893
19 GRAPHIC g110563ex99_2p20g1.jpg GRAPHIC 281925
20 GRAPHIC g110563ex99_2p21g1.jpg GRAPHIC 391533
21 GRAPHIC g110563ex99_2p22g1.jpg GRAPHIC 265372
22 GRAPHIC g110563ex99_2p23g1.jpg GRAPHIC 365645
23 GRAPHIC g110563ex99_2p24g1.jpg GRAPHIC 376251
24 GRAPHIC g110563ex99_2p25g1.jpg GRAPHIC 267067
25 GRAPHIC g110563ex99_2p26g1.jpg GRAPHIC 455269
26 GRAPHIC g110563ex99_2p27g1.jpg GRAPHIC 383450
27 GRAPHIC g110563ex99_2p28g1.jpg GRAPHIC 350173
28 GRAPHIC g110563ex99_2p29g1.jpg GRAPHIC 353513
29 GRAPHIC g110563ex99_2p2g1.jpg GRAPHIC 738224
30 GRAPHIC g110563ex99_2p30g1.jpg GRAPHIC 356556
31 GRAPHIC g110563ex99_2p31g1.jpg GRAPHIC 256082
32 GRAPHIC g110563ex99_2p32g1.jpg GRAPHIC 379216
33 GRAPHIC g110563ex99_2p33g1.jpg GRAPHIC 257760
34 GRAPHIC g110563ex99_2p34g1.jpg GRAPHIC 248798
35 GRAPHIC g110563ex99_2p35g1.jpg GRAPHIC 277958
36 GRAPHIC g110563ex99_2p36g1.jpg GRAPHIC 342020
37 GRAPHIC g110563ex99_2p37g1.jpg GRAPHIC 407763
38 GRAPHIC g110563ex99_2p38g1.jpg GRAPHIC 443717
39 GRAPHIC g110563ex99_2p3g1.jpg GRAPHIC 476066
40 GRAPHIC g110563ex99_2p4g1.jpg GRAPHIC 340403
41 GRAPHIC g110563ex99_2p5g1.jpg GRAPHIC 329807
42 GRAPHIC g110563ex99_2p6g1.jpg GRAPHIC 354386
43 GRAPHIC g110563ex99_2p7g1.jpg GRAPHIC 264732
44 GRAPHIC g110563ex99_2p8g1.jpg GRAPHIC 365287
45 GRAPHIC g110563ex99_2p9g1.jpg GRAPHIC 275412
  Complete submission text file 0001193125-24-003956.txt   18042593

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nams-20240104.xsd EX-101.SCH 3853
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nams-20240104_def.xml EX-101.DEF 13696
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE nams-20240104_lab.xml EX-101.LAB 22726
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nams-20240104_pre.xml EX-101.PRE 14664
47 EXTRACTED XBRL INSTANCE DOCUMENT d110563d8k_htm.xml XML 5511
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41562 | Film No.: 24518472
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)